In vitro activity of ceftazidime-avibactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa from sub-Saharan Africa: ATLAS Global Surveillance Program 2017

In vitro activity of ceftazidime-avibactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa from sub-Saharan Africa: ATLAS Global Surveillance Program 2017–2021

Published:2023-12 Issue: Volume:35 Page:93-100
ISSN:2213-7165
Container-title:Journal of Global Antimicrobial Resistance
language:en
Short-container-title:Journal of Global Antimicrobial Resistance

Author:

Wise Mark G.^ORCID,Karlowsky James A.,Hackel Meredith A.,Harti Mohamed Amine,Ntshole Bontle M.E.,Njagua Eva Njeri,Oladele Rita,Samuel Catherine,Khan Shameema^ORCID,Wadula Jeannette,Lowman Warren^ORCID,Lembede Busisani W.,Sahm Daniel F.

Funder

Pfizer

Publisher

Elsevier BV

Subject

Microbiology (medical),Immunology,Immunology and Allergy,Microbiology

Reference24 articles.

1. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance;Magiorakos;Clin Microbiol Infect,2012

2. Difficult-to-treat resistance in Gram-negative bacteremia at 173 US hospitals: retrospective cohort analysis of prevalence, predictors, and outcome of resistance to all first-line agents;Kadri;Clin Infect Dis,2018

3. Review and mapping of carbapenem-resistant Enterobacteriaceae in Africa: using diverse data to inform surveillance gaps;Mitang;Int J Antimicrob Agents,2018

4. Activity of ceftazidime-avibactam against extended-spectrum- and AmpC β-lactamase-producing Enterobacteriaceae collected in the INFORM global surveillance study from 2012 to 2014;Karlowsky;Antimicrob Agents Chemother,2016

5. In vitro susceptibility of global surveillance isolates of Pseudomonas aeruginosa to ceftazidime-avibactam (INFORM 2012 to 2014);Nichols;Antimicrob Agents Chemother,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of in vitro antimicrobial activity of ceftazidime-avibactam and phenotypic synergy testing with aztreonam against carbapenem resistant Gram-negative bacilli in a tertiary care hospital;Journal of Laboratory Physicians;2024-07-10

2. Global trends in carbapenem- and difficult-to-treat-resistance among World Health Organization priority bacterial pathogens: ATLAS surveillance program 2018–2022;Journal of Global Antimicrobial Resistance;2024-06

3. The Importance of Carbapenemase-Producing Enterobacterales in African Countries: Evolution and Current Burden;Antibiotics;2024-03-24